Bayer AG NA (BAYN)

Bucharest
Currency in RON
106.6200
+2.9000(+2.80%)
Closed
BAYN Scorecard
Full Analysis
Net income is expected to grow this year
Fair Value
Day's Range
104.9000106.6200
52 wk Range
93.0000152.8000
Key Statistics
Edit
Bid/Ask
363.50 / 368.85
Prev. Close
103.72
Open
104.9
Day's Range
104.9-106.62
52 wk Range
93-152.8
Volume
3
Average Vol. (3m)
460
1-Year Change
-28.4%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
BAYN Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
3 analysts have revised their earnings upwards for the upcoming period
Show more

Bayer AG NA Company Profile

Bayer Aktiengesellschaft operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women’s health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents, as well as cell and gene therapy. The Consumer Health segment markets nonprescription over-the-counter medicines, medical products, medicated skincare products, nutritional supplements, and self-care solutions in dermatology, nutritional supplements, pain and cardiovascular risk prevention, digestive health, allergy, and cold and cough. The Crop Science segment offers chemical and biological crop protection products, improved plant traits, seeds, digital solution, and pest and weed control products, as well as customer service for agriculture. This segment provides breeding, propagation, and production/processing of seeds, including seed dressing. It has a collaboration agreement with MD Anderson Cancer Center to develop oncology drugs; research and license agreement with Dewpoint Therapeutics, Inc. for the development of new treatments for cardiovascular and gynecological diseases; collaboration agreement with Exscientia Ltd, Foundation Medicine Inc., and Evotec AG; research collaboration with Arvinas Inc.; strategic research partnership with University of Oxford to develop novel gynecological therapies; Kyoto University to identify new drugs candidates for the treatment of pulmonary diseases; and collaboration and license agreement with Cytokinetics for the development and commercialization of aficamten. It distributes its products through wholesalers, pharmacies and pharmacy chains, supermarkets, online and other retailers, and hospitals, as well as directly to farmers. The company was founded in 1863 and is headquartered in Leverkusen, Germany.

Employees
94245
Market
Romania

Compare BAYN to Peers and Sector

Metrics to compare
BAYN
Peers
Sector
Relationship
P/E Ratio
0.0x16.9x−0.6x
PEG Ratio
0.000.070.00
Price / Book
0.0x2.4x2.6x
Price / LTM Sales
0.0x2.7x3.1x
Upside (Analyst Target)
0.0%30.2%48.8%
Fair Value Upside
Unlock16.7%7.5%Unlock

Earnings

Latest Release
-
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

People Also Watch

86.42
NVO
-0.86%
703.00
ASML
-1.72%
56.880
MBGn
-1.11%
684.20
LVMH
-1.82%
129.84
NVDA
+0.90%

FAQ

What Is the Bayer (BAYN) Stock Price Today?

The Bayer stock price today is 106.62

What Stock Exchange Does Bayer Trade On?

Bayer is listed and trades on the Bucharest stock exchange.

What Is the Stock Symbol for Bayer?

The stock symbol for Bayer is "BAYN."

What Is the Bayer Market Cap?

As of today, Bayer market cap is 102.40B.

What is Bayer Earnings Per Share?

The Bayer EPS is -0.896.

From a Technical Analysis Perspective, Is BAYN a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.